8-K
filed October 15, 2024, 7:59 PM ET
ticker IVF
CIK 0001417926
M&A
confidence high
sentiment neutral
materiality 0.85
INVO Fertility, Inc. (IVF): M&A transaction — INVO Bioscience completes acquisition of NAYA, changes name to NAYA Biosciences
INVO Fertility, Inc.
- NAYA stockholders receive 118,148 INVO common shares and 30,375 Series C-1 Preferred per share.
- $8.58M NAYA debt converted into 669,508 INVO common shares and 8,576 Series C-2 Preferred.
- Remaining $3.93M NAYA debt exchanged for 7% convertible debenture due December 2025.
- Name changed to NAYA Biosciences, Inc.; ticker to change from INVO to NAYA on Nasdaq.
- Dr. Daniel Teper appointed President and board director; Lyn Falconio also named to board.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Daniel Teper was appointed as President at INVO Fertility, Inc..
- Action
- appointed
- Role
- President
Exact text from the filing
the board of directors appointed Dr. Teper as President of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Daniel Teper was appointed as Director at INVO Fertility, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Company’s board of directors appointed Dr. Daniel Teper and Lyn Falconio as directors of the Company to fill two vacancies on the board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Lyn Falconio was appointed as Director at INVO Fertility, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Company’s board of directors appointed Dr. Daniel Teper and Lyn Falconio as directors of the Company to fill two vacancies on the board.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
INVO Fertility, Inc.: Company changed its corporate name to NAYA Biosciences, Inc. via an Amendment to Articles of Incorporation (effective 2024-10-15).
- Change
- charter amendment
- Effective
- 2024-10-15
Exact text from the filing
On October 15, 2024, the Company changed its corporate name to NAYA Biosciences, Inc., pursuant to an Amendment to Articles of Incorporation filed with the Nevada Secretary of State on October 15, 2024 (the “ Name Change ”).
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.7
INVO Fertility, Inc. completed an acquisition involving NAYA Biosciences, Inc. for 118,148 shares of the Company's common stock and 30,375 shares of the Company's newly-designated Series C-1 Convertible Preferred Stock (closed 2024-10-11).
- Action
- acquisition
- Counterparty
- NAYA Biosciences, Inc.
- Consideration
- 118,148 shares of the Company's common stock and 30,375 shares of the Company's newly-designated Series C-1 Convertible Preferred Stock
- Closing
- 2024-10-11
Exact text from the filing
f NAYA Biosciences, Inc., a Delaware corporation (“ NAYA ”) pursuant to an Amended and Restated Agreement and Plan of Merger by and among the Company, NAYA, and INVO Merger
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
INVO Fertility, Inc. underwent a change of control involving NAYA Biosciences, Inc. for 118,148 shares of the Company's common stock and 30,375 shares of the Company's newly-designated Series C-1 Convertible Preferred Stock (closed 2024-10-11).
- Action
- change of control
- Counterparty
- NAYA Biosciences, Inc.
- Consideration
- 118,148 shares of the Company's common stock and 30,375 shares of the Company's newly-designated Series C-1 Convertible Preferred Stock
- Closing
- 2024-10-11
Exact text from the filing
f NAYA Biosciences, Inc., a Delaware corporation (“ NAYA ”) pursuant to an Amended and Restated Agreement and Plan of Merger by and among the Company, NAYA, and INVO Merger
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.